EUTHYMICS BIOSCIENCE INC has a total of 27 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2002. It filed its patents most often in Japan, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CUENOUD BERNARD, GLAXO LAB SA and ARBISER JACK L.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 9 | |
#2 | United States | 8 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Australia | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mckinney Anthony Alexander | 7 |
#2 | Corley Edward G | 6 |
#3 | Simmons Bryon | 6 |
#4 | Chen Zhengming | 5 |
#5 | Skolnick Phil | 5 |
#6 | Jerry A Murry | 3 |
#7 | Hagen Eric J | 3 |
#8 | Xu Feng | 3 |
#9 | Fava Maurizio | 3 |
#10 | Feng Sue | 3 |
Publication | Filing date | Title |
---|---|---|
EP3068226A1 | Novel methods | |
US2015005359A1 | Combinations and methods | |
US2013345279A1 | Polymorphs of azabicyclohexane | |
WO2014182279A1 | Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disorders | |
AU2012203400A1 | Novel polymorphs of azabicyclohexane | |
KR20140053822A | Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters |